Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective study

Gut Microbes. 2023 Dec;15(2):2249150. doi: 10.1080/19490976.2023.2249150.

Abstract

Vitamin D, microbiota, and the Mediterranean diet (MedDiet) have been the focus of recent research due to their potential role in maintaining overall health. We hypothesize that MedDiet may alter the gut microbiota profile through changes in vitamin D levels. We aimed to investigate changes in gut microbiota and serum vitamin D levels after a MedDiet within a lifestyle intervention. The study included 91 patients with obesity and metabolic syndrome, who were categorized based on their serum vitamin D levels as having either optimal or low 25-hydroxyvitamin D [25(OH)D levels]. The profile of the gut microbiota was analyzed by the 16S rRNA sequencing, inferring its functionality through PICRUsT. Participants underwent a hypocaloric MedDiet and change in their lifestyle for 1 year, and the profile and functionality of their gut microbiota were evaluated by analyzing inter-individual differences in time. At baseline, gut microbiota profiles qualitatively differed between participants with Optimal or Low 25(OH)D levels [Unweighted (p = 0.016)]. Moreover, participants with Optimal 25(OH)D levels showed a higher gut microbiota diversity than those with Low 25(OH)D levels (p < 0.05). The differential analysis of abundance between the Low and Optimal 25(OH)D groups revealed differences in the levels of Bacteroides, Prevotella, and two Clostridiales features. After 1-year dietary intervention, both groups increased their 25(OH)D levels. Furthermore, both groups did not show significant differences in gut microbiota diversity, although the Low 25(OH)D group showed greater improvement in gut microbiota diversity by comparing at baseline and after dietary intervention (p < 0.05). Changes in specific bacterial taxa were observed within each group but did not differ significantly between the groups. Metabolic pathway analysis indicated differences in microbial functions between the groups (p < 0.05). These findings suggest that 25(OH)D status is associated with gut microbiota composition, diversity, and functionality, and lifestyle intervention can modulate both gut microbiota and 25(OH)D levels, potentially influencing metabolic pathways.

Keywords: 25-hydroxyvitamin D; MedDiet; gut microbiota; mediterranean diet; metabolic syndrome; obesity; vitamin D.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cross-Sectional Studies
  • Diet, Mediterranean*
  • Gastrointestinal Microbiome*
  • Humans
  • Life Style
  • Metabolic Syndrome* / therapy
  • Obesity / therapy
  • Prospective Studies
  • RNA, Ribosomal, 16S / genetics
  • Vitamin D
  • Vitamins

Substances

  • RNA, Ribosomal, 16S
  • Vitamin D
  • Vitamins

Grants and funding

The work was supported by the Instituto de Salud Carlos III [CD22/00053]; Instituto de Salud Carlos III [CD19/00216]; Instituto de Salud Carlos III [PI18/01160, PI21/01677]; Instituto de Salud Carlos III [CPII21-00013]; Servicio Andaluz de Salud [RC-0001-2018, C-0029-2014].